Prognostic value of dobutamine echocardiography in patients after q-wave or non–q-wave acute myocardial infarction

V_alue of First Day Angiography/Angioplasty I_n Evolving N_on-ST Segment Elevation Myocardial Infarction: An O_pen Multicenter Randomized Trial. The VINO Study

“…Overall, only 33% of the patients underwent angiography and 23% percutaneous coronary intervention [32] . The in-hospital mortality of patients with acute non-ST-elevation myocardial infarction is lower than those with Q wave myocardial infarction, but its longterm prognosis is similar or worse [33][34][35][36][37][38][39][40][41] . These patients are usually older, have important co-morbidity and more risk factors.…”

Implementation of Cardovascular Cell Therapy Network trials: challenges, innovation and lessons learned from experience in the CCTRN

“…Additionally, the majority of patients who present with acute coronary syndrome present with either unstable angina or non-STEMI which do not necessarily portend lower long-term risk. Specifically, patients presenting with non-STEMI have a higher likelihood of residual ischemia which is associated with a significant increase in mortality [30, 31]. While the incidence of STEMI is decreasing, the occurrence of non-STEMI has not changed significantly with estimation of 1year post admission fatality rate of 18% [32].…”

Advances in Myocardial Infarction Management

“…In the GUSTO-IIb trial, the 6-month rate of reinfarction was 9.8% for patients initially presenting with NSTEMI compared with 6.2% for patients initially presenting with STEMI [59]. This similar, or worse, long-term prognosis for patients with NSTEMI is thought to be related to a higher prevalence of multivessel coronary artery disease and residual ischemia [59,73,74]. Not surprising, other characteristics associated with worse long-term prognosis for NSTEMI include older age [37,75], the presence of diabetes [76] and a history of prior MI or CHF [77].…”